English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 858770      Online Users : 774
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    國家衛生研究院 NHRI >  Browse by Title

    Jump to: [Chinese Items]   [0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
    or enter the first few letters:   

    Showing items 1741-1750 of 12927. (1293 Page(s) Totally)
    << < 170 171 172 173 174 175 176 177 178 179 > >>
    View [10|25|50] records per page
    DateTitleRelation
    2010-01-30 Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B Life Sciences. 2009 Jan 30;86(5-6):199-206.
    2020-01 Both igM and igG antibodies against polyethylene glycol can alter the biological activity of methoxy polyethylene glycol-epoetin beta in mice Pharmaceutics. 2020 Jan;12(1):Article number 15.
    2009-01 Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: A randomized trial comparing two injection volumes Clinical Rehabilitation. 2009 Jan;23(1):64-71.
    2014-03-20 Bovine induced pluripotent stem cells are more resistant to apoptosis than testicular cells in response to mono-(2-ethylhexyl) phthalate International Journal of Molecular Sciences. 2014 Mar 20;15(3):5011-5031.
    2021-10-25 BPI overexpression suppresses Treg differentiation and induces exosome-mediated inflammation in systemic lupus erythematosus Theranostics. 2021 Oct 25;11(20):9953-9966.
    2014-12 BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71 Antiviral Research. 2014 Dec;112:18-25.
    2013-04-07 BPR000K, a novel Aurora kinase inhibitor Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 300-MEDI.
    2011-01 BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities Cancer Science. 2011 Jan;102(1):182-191.
    2022-11-15 BPR0C261, an analogous of microtubule disrupting agent D-24851 enhances the radiosensitivity of human non-small cell lung cancer cells via p53-dependent and p53-independent pathways International Journal of Molecular Sciences. 2022 Nov 15;23(22):Article number 14083.
    2013-11 BPR0C305, an orally active microtubule-disrupting anticancer agent Anticancer Drugs. 2013 Nov;24(10):1047-1057.
    Showing items 1741-1750 of 12927. (1293 Page(s) Totally)
    << < 170 171 172 173 174 175 176 177 178 179 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback